Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial) [0.03%]
COPD患者的支气管扩张剂反应性（来自UPLIFT试验的数据）
D Tashkin,B Celli,M Decramer et al.
D Tashkin et al.
Outcomes for COPD pharmacological trials: From lung function to biomarkers [0.03%]
COPD药物试验的结果：从肺功能到生物标志物
M Cazzola,W MacNee,F J Martinez et al.
M Cazzola et al.
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD [0.03%]
噻托溴铵对慢性阻塞性肺病患者痰和血清炎症标志物及急性加重的影响
D J Powrie,T M A Wilkinson,G C Donaldson et al.
D J Powrie et al.
Hemoptysis in young adults [0.03%]
年轻成年人的咯血症状
Herbert Peter Know,Vincent Mysliwiec,Alexander Niven et al.
Herbert Peter Know et al.
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors - March 2008 update [0.03%]
肿瘤坏死因子α抑制剂治疗备选者中关节炎症疾病的潜伏和活动结核的诊断和处理建议—2008年3月更新版
João Eurico Fonseca,Helena Lucas,Helena Canhão et al.
João Eurico Fonseca et al.
The Portuguese Society of Rheumatology and the Portuguese Society of Pulmonology have updated the guidelines for the diagnosis and treatment of latent tuberculosis infection (LTBI) and active tuberculosis (ATB) in patients with inflammatory...
The Portuguese Journal of Pulmonology and other Portuguese Society of Pulmonology publications [0.03%]
葡萄牙胸科学会的期刊及其他出版物
Renato Sotto-Mayor
Renato Sotto-Mayor
António Segorbe Luís
António Segorbe Luís
Bárbara Parente
Bárbara Parente
Elvira Richter
Elvira Richter
New, easy-to-use tools for standardised and quality-controlled genotyping of Mycobacterium tuberculosis complex strains [0.03%]
用于结核分枝杆菌复合群基因分型的标准且质量控制的新型易用工具
Caroline Allix-Béguec,Christine Hubans,Stéphanie Ferreira;Philip Supply. Electronic address: philip.supply@genoscreen.fr
Caroline Allix-Béguec